Drug products: Diazemuls Novum, Diazepam, Diazepam Autoinjector, Diazepam CF, Diazepam Desitin, Diazepam Injection BP, Diazepam Injection, USP, Diazepam Orifarm, Diazepam Pilum, Diazepam ratiopharm, Diazepam Renaudin, Diazepam-Lipuro, Diazepam-Ratiopharm, Stesolid Novum, Stesolid®, Stesolid® novum, Stesolid® Rektal Prefill, Valium, Valium Roche, Valtoco
ATC code: N05BA01
Diazepam has effect in both men and women. Sex differences in adverse effects have been described but it’s unclear what is directly associated with the drug. The reported pharmacokinetic differences are conflicting and of doubtful clinical relevance.
There are conflicting results regarding interaction between some benzodiazepines and contraceptives containing ethinyl estradiol. Some studies have shown a considerably slower metabolism of benzodiazepines while other studies have not shown any interaction with ethinyl estradiol.
Several studies have been conducted to assess differences between men and women in single-dose diazepam pharmacokinetics. The results are somewhat conflicting. Some studies demonstrate larger volume of distribution in women than in men [5-7] while other show no difference . Similarly, clearance of diazepam (total and free) has in some studies been shown to be higher in women [5, 6] while others find it to be higher in men . Clearance of the active metabolite desmethyldiazepam has been shown to be higher in men . Results are inconsistent also regarding elimination half-life. Some studies show shorter half-life in men  while other studies find no sex difference .
Analysis of diazepam metabolites in urine samples has shown higher fractions of temazepam and lower fractions of oxazepam and desmethyldiazepam in samples from women. This may be due to increased CYP3A4 activity in women compared to men .
Free fraction of diazepam was shown to be higher in women than in men with renal insufficiency (16 men, 12 women) receiving single-dose diazepam 10 mg .
Hydroxyzine was compared with diazepam as premedication before surgery (49 men, 59 women) in a double-blind randomized manner. In men, there was no difference between the effect of diazepam and hydroxyzine. In women, hydroxyzine was better than diazepam in relieving anxiety .
Sex differences in the effect of diazepam on psychomotor skills were investigated in two placebo-controlled double-blind trials. In the first trial, healthy volunteers (78 men, 78 women) were divided into four groups receiving either an oral dose of 10 mg diazepam, placebo, alcohol in addition to diazepam, or a nonalcoholic drink in addition to placebo. In the second trial, subjects received diazepam or placebo in doses corrected for body weight. Results showed that in women receiving diazepam, psychomotor skills (cognitive, motor and sensory performances) were impaired more than in men. Also, after diazepam administration women experienced clumsiness to a greater extent than men did. The effect of diazepam combined with alcohol did not differ between men and women .The frequency of adverse effects of benzodiazepines experienced in psychiatric outpatients has been evaluated in a questionnaire (60 men, 19 women). All women and 91% of men had at least one adverse effect. The mean number of adverse events was 4.8 in both men and women. The most commonly reported adverse effects in both men and women were sleepiness, slowness and fatigue. The most evident sex difference was the higher prevalence of dizziness in women (31%) than men (6%) .The risk of falls when using benzodiazepines was studied in a registry study (124009 men, 197413 women). Higher age and female sex was associated with a higher incidence of falls among benzodiazepine users and controls. The risk of falling was higher among benzodiazepine users, more pronouncedly so in men. A history of treatment of alcohol abuse was an important risk factor for falls in this group with an odds ratio of 10.7 in men and 4.3 in women. The benzodiazepines showing the highest increase in risk of falls were flurazepam and triazolam followed by, oxazepam, lorazepam and diazepam in falling order .
Ethinyl estradiol may increase exposure of diazepam, possibly due to inhibition of CYP2C19 and CYP3A4 catalysed metabolism of diazepam by ethinyl estradiol. The extent of this is not of that magnitude that dose adjustment normally will be needed .In vitro data has shown that free fraction of diazepam was higher in women taking oral contraceptives than in women not taking oral contraceptives. Women without oral contraceptives had higher free fraction of diazepam than men . In part, these findings are supported by a small single-dose study (6 men, 5 women on oral contraceptives) on diazepam disposition. Women had lower plasma clearance of diazepam than men. Theoretically, long-term treatment will therefore result in higher plasma concentrations of diazepam in women than in men. In contrast, no difference between men and women without oral contraceptives was shown in the control group (11 men, 10 women) . A third study (16 women, 8 of them on oral contraceptives) failed to show any difference in diazepam free fraction between women on and free from oral contraceptives. Women on oral contraceptives were shown to have longer elimination half-life of diazepam and also, lower total metabolic clearance . One study (10 men, 8 women on oral contraceptives, no control group without oral contraceptives) also showed that the psychomotor effects of diazepam varied depending on time in the cycle . Regarding drug-drug interactions aspects, please consult Janusmed Interactions (in Swedish, Janusmed interaktioner).
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
In a small double-blind Mexican study in young healthy volunteers (9 men, 9 women), EEG was recorded after administration of an oral dose of 5 mg diazepam as well as after placebo. During the recording session the subjects were awake and had their eyes open. The influence of diazepam on EEG activity (alpha, theta, and delta rhythm) differed between men and women. This may be associated with female sex hormones and sex differences in brain organization .A Swedish register-based study conducted on a geriatric population (280623 men, 450482 women, age ≥75) has shown a higher probability for women to use benzodiazepines/benzodiazepine related drugs .
Date of litterature search: 2015-04-17
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson